Literature DB >> 8328774

Experimental study of transplacental passage of alpha interferon by two assay techniques.

A Waysbort1, M Giroux, V Mansat, M Teixeira, J C Dumas, J Puel.   

Abstract

Two methods of assaying alpha interferon (IFN-alpha) were compared during an experiment aimed at determining whether IFN-alpha crosses the human placenta. Human placentas, collected after delivery following a normal pregnancy to term, were catheterized on both sides: fetal and maternal. The IFN-alpha was introduced in known amounts in the maternal circulation and was assayed in the efferent fetal fluid. The following two detection methods were used: radioimmunoassay by competition with [125I]IFN-alpha and assay with a biological system in which IFN-alpha protected Madin-Darby bovine kidney cells from destruction by vesicular stomatitis virus. The results obtained by the two methods were in perfect agreement for the efferent fetal fluid samples. They showed the absence of placental transfer of IFN-alpha. The biological method was found to be more sensitive than radioimmunoassay for low IFN-alpha titers (< 10 IU/ml) but was less reproducible, probably owing to the use of twofold dilutions. The specificities of the two methods were similar and their practicalities were equivalent; the biological method, however, was less costly. The study illustrates the complementarity of the two methods, which were based on different principles. The agreement obtained between the two methods provides a clear confirmation of the experimental results.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8328774      PMCID: PMC187945          DOI: 10.1128/AAC.37.6.1232

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Immunosorbent binding bioassay: a solid phase biological immunoassay for the titration of antisera to alpha interferons.

Authors:  R M L'Haridon
Journal:  J Immunoassay       Date:  1991

2.  Effects of pH on antipyrine transfer across the human placenta ex vivo.

Authors:  M Giroux; G Campistron; F Faure; J C Dumas; Y Coulais; R Desprats; H Grandjean; G Houin; G Pontonnier
Journal:  Dev Pharmacol Ther       Date:  1990

3.  Pronounced antiviral activity of human interferon on bovine and porcine cells.

Authors:  I Gresser; M T Bandu; D Brouty-boye; M Tovey
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

4.  Immunoradiometric assay of human leukocyte interferon using monoclonal antibody.

Authors:  D S Secher
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

5.  Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer.

Authors:  A Lopez-Anaya; J D Unadkat; L A Schumann; A L Smith
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

Review 6.  HIV-1 infection in pregnancy: implications for women and children.

Authors:  M L Newell; C S Peckham; P Lepage
Journal:  AIDS       Date:  1990       Impact factor: 4.177

7.  Three-drug synergistic inhibition of HIV-1 replication in vitro by zidovudine, recombinant soluble CD4, and recombinant interferon-alpha A.

Authors:  V A Johnson; M A Barlow; D P Merrill; T C Chou; M S Hirsch
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

8.  Transfer of zidovudine (AZT) by human placenta.

Authors:  L Liebes; S Mendoza; D Wilson; J Dancis
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

9.  Protective effect of interferon on target cells exposed to cellular cytotoxicity.

Authors:  M Bergeret; A Grégoire; C Chany
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

10.  [Production of human type I interferon by lymphocytes in contact with cells infected by herpesvirus and fixed with glutaraldehyde].

Authors:  P Lebon; M J Commoy-Chevalier; B Robert-Galliot; A Morin; C Chany
Journal:  C R Seances Acad Sci D       Date:  1980-01-07
View more
  14 in total

Review 1.  Tolerability of treatments for viral hepatitis.

Authors:  A Gervais; N Boyer; P Marcellin
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

Authors:  Urs Meyer; Joram Feldon; Benjamin K Yee
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

3.  Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C.

Authors:  Anne Boulestin; Nassim Kamar; Florence Legrand-Abravanel; Karine Sandres-Saune; Laurent Alric; Jean-Pierre Vinel; Lionel Rostaing; Jacques Izopet
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 4.  Management of women with multiple sclerosis through pregnancy and after childbirth.

Authors:  Patricia K Coyle
Journal:  Ther Adv Neurol Disord       Date:  2016-03-02       Impact factor: 6.570

Review 5.  Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis.

Authors:  M Haria; P Benfield
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

6.  Subclinical in utero Zika virus infection is associated with interferon alpha sequelae and sex-specific molecular brain pathology in asymptomatic porcine offspring.

Authors:  Ivan Trus; Daniel Udenze; Brian Cox; Nathalie Berube; Rebecca E Nordquist; Franz Josef van der Staay; Yanyun Huang; Gary Kobinger; David Safronetz; Volker Gerdts; Uladzimir Karniychuk
Journal:  PLoS Pathog       Date:  2019-11-14       Impact factor: 6.823

7.  Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.

Authors:  Marta Giannini; Emilio Portaccio; Angelo Ghezzi; Bahia Hakiki; Luisa Pastò; Lorenzo Razzolini; Elisa Piscolla; Laura De Giglio; Carlo Pozzilli; Damiano Paolicelli; Maria Trojano; Maria Giovanna Marrosu; Francesco Patti; Loredana La Mantia; Gianluigi Mancardi; Claudio Solaro; Rocco Totaro; Maria Rosaria Tola; Giovanna De Luca; Alessandra Lugaresi; Lucia Moiola; Vittorio Martinelli; Giancarlo Comi; Maria Pia Amato
Journal:  BMC Neurol       Date:  2012-10-22       Impact factor: 2.474

8.  Transplacental passage of interleukins 4 and 13?

Authors:  Robert H Lim; Lester Kobzik
Journal:  PLoS One       Date:  2009-03-02       Impact factor: 3.240

Review 9.  Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.

Authors:  Margaux Louchet; Jeanne Sibiude; Gilles Peytavin; Olivier Picone; Jean-Marc Tréluyer; Laurent Mandelbrot
Journal:  Am J Obstet Gynecol MFM       Date:  2020-06-22

10.  Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero.

Authors:  Malin Hedlund; Gudny Ella Thorlacius; Margarita Ivanchenko; Vijole Ottosson; Nikolaos Kyriakidis; Linda Lagnefeldt; Joanna Tingström; Allan Sirsjö; Anders A Bengtsson; Emma Aronsson; Kristina Gemzell-Danielsson; Lars Ronnblom; Gunnar Bergman; Alexander Espinosa; Sven-Erik Sonesson; Maija-Leena Eloranta; Marie Wahren-Herlenius
Journal:  RMD Open       Date:  2020-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.